A few days ago, Dr. Miguel Martin, chief of oncology at Madrid's Gregorio Maranon Hospital, gave an interesting lecture. The expert, before an audience of mainly women and headquarters of the Junta de Madrid of the Spanish Association Against Cancer (AECC), spoke about breast cancer chemoprevention.
With frequent and severe than is cancer, the researchers for years trying to find easy to consume a drug, with reasonable price and with mild side effects and above all-assumable, able to reduce the risk of cancer.
One of the targets on which are set based on the influence of hormones in it, is breast cancer. Malignant tumors of this gland, in many cases, depend for their growth quintessential female hormone, estrogen. Buy Triactol So if administering a drug capable of blocking estrogen receptors in breast tissue is achieved significantly lower incidence of cancer mortality more fear and more women occurs, it will mean a giant step forward.
That seems to have already occurred. A few months ago was published in the bible of medicine, as doctors call the 'New England Journal of Medicine (NEJM), a large multicenter, multinational clinical trial which proved beyond doubt that a product, the examestano lowers the risk of breast cancer in postmenopausal women with certain characteristics between 50% and 60%. Decrease the chances of developing this type of tumor in these percentages is something that had not been achieved so far.
And besides, it has been priced in euros and discreet side effects, which is also good news. The examestano is generic (word so fashionable in recent months), is affordable and does not cause unreasonable adverse effects. Now it would be both. First, to get to educate women to find out if your profile is a candidate for chemoprevention. Second, ensure that preventive medicine is present mainly in the minds of healthy people. So, government and education institutions should contribute to the public sanitary. It is much cheaper than to fix problems later. And of lives saved and suffering avoided will have to speak many more times.